🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Novozymes 
Healthcare & biotech / Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Currency exchange rate fluctuations: Changes in currency exchange rates can have a significant impact on Novozymes’ earnings due to its international presence.
2. Dependence on selected markets: Novozymes generates a large portion of its revenue from B2B channels, meaning that it is almost entirely dependent on a select few markets.
3. Lack of market share: Novozymes does not currently have a dominant market share in its industry, which could potentially be disadvantageous in the face of increasing competition.
4. Increasing raw materials cost: Raw materials costs are an important factor in production costs, and if the cost of raw materials increases, it could cut significantly into Novozymes’ gross margins.
5. Product reliability: The reliability of Novozymes’ products is always a significant concern and any product defect could lead to severe losses.
Wait! There's more — sign up for free or log in